Analysts: this year best year ever for Amgen

Tomorrow the American Amgen will report its past quarters results. For this year Amgen 's (located in ) revenue will be around 26.76 billion USD. This is according to the average of the analysts' estimates. The expected revenue would be the highest in her history. This is slightly more than 2022's revenue of 26.32 billion USD.

Historical revenues and results Amgen plus estimates 2023

The analysts expect for 2023 a net profit of 9.57 billion USD. For this year the majority of the analysts, consulted by press agency Thomson Reuters, expects a profit per share of 17.74 USD. The price/earnings-ratio is then 14.06.

Huge dividend Amgen

Per share the analysts expect a dividend of 8.43 USD per share. Amgen 's dividend yield thus equals 3.38 percent. The average dividend yield of the biotech companies equals a good 3.55 percent.

Amgen 's market capitalization is around 139.3 billion USD.

Historical stock prices Amgen

At 15.44 the stock trades 0.31 percent higher at 249.5 USD.

Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.